A controlled release formulation containing diacerein or its analogs is provided. Also provided is a method of lowering blood levels of uric acid using this formulation. In one embodiment the invention provides a controlled release formulation with reduced adverse side effects and/or higher bioavailability comprising an immediate release layer and an extended release layer.